Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
celgene
congress
drug prices
nash
olivier brandicourt
pbms
pfizer
pharmacy benefit managers
pricing
2019
abbvie
What
drug
3
×
bio
roundup
adu
advanced
alnylam’s
approval
approved
away
beats
bff
bids
biogen
bringing
ceos
complicated
conference
dc
deals
depression
devoted
dire
disease
easl
executives
form
gathered
gene
good
group
groups
hearing
heart
held
help
kicked
liver
lower
major
medical
Language
Current search:
sanofi
×
drug
×
" bristol-myers squibb "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away